IL6 and type 2 diabetes mellitus: Results provided by miEAA overrepresentation analyses also indicated phenomena related to inflammation with records regarding chemokines, cytokines, interleukins (including well-known markers of T2DM–IL-6 and IL-18), RANKL signaling, lymphocytes activation and migration (Figure A7 and Figure A8).